Literature DB >> 11062038

Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits.

S M Best1, S V Collins, P J Kerr.   

Abstract

The coevolution of myxoma virus and the wild European rabbit in Australia and the development of resistance to myxomatosis in wild rabbits have been well described. However, the mechanism of resistance to myxomatosis in wild rabbits is not understood. To determine the basis of resistance, the pathogenesis of the virulent standard laboratory strain (SLS) and the attenuated Uriarra (Ur) strain of myxoma virus were examined in Australian wild rabbits that have been naturally selected in the field for resistance to myxomatosis and in laboratory rabbits which have never been selected for resistance. Virus was localized in tissue sections by immunofluorescence. In all cases virus antigen was initially present in dendritic cells of the dermis before localizing predominantly to the epidermis by Day 6. Antigen-containing cells were detected in the lymph nodes by 24 h after inoculation. Virus replication occurred predominantly in T lymphocytes of the paracortex but SLS also replicated in germinal centers. SLS replication induced loss of most lymphocytes from the lymph nodes of susceptible rabbits. Apoptosis of lymphocytes within the lymph nodes was a major feature of all infections. These apoptotic cells did not contain detectable viral antigen but were often adjacent to infected cells. Ongoing apoptosis of lymphocytes within lymph nodes was also a feature of the recovery phase when very few or no virus-infected cells could be detected. Differences between virulent and attenuated viruses in the wild and laboratory rabbits were predominantly in the degree of tissue pathology in the draining lymph node and distal lymph node and in the type of inflammatory responses, particularly in the skin. SLS infection of laboratory rabbits was associated with a very mild inflammatory response, often distant from the site of virus replication and comprised predominantly of neutrophils. In contrast, Ur-infected rabbits and SLS-infected wild rabbits had an intense inflammatory response adjacent to the site of virus replication and this was comprised predominantly of mononuclear cells. Both the initial infection of dendritic cells and the ongoing destruction of lymphocytes provide obvious mechanisms for the suppression of the immune response by myxoma virus. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 11062038     DOI: 10.1006/viro.2000.0505

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vector.

Authors:  S Top; E Foulon; B Pignolet; M Deplanche; C Caubet; C Tasca; S Bertagnoli; G Meyer; G Foucras
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 2.  Viral biocontrol: grand experiments in disease emergence and evolution.

Authors:  Francesca Di Giallonardo; Edward C Holmes
Journal:  Trends Microbiol       Date:  2014-10-31       Impact factor: 17.079

3.  Next step in the ongoing arms race between myxoma virus and wild rabbits in Australia is a novel disease phenotype.

Authors:  Peter J Kerr; Isabella M Cattadori; June Liu; Derek G Sim; Jeff W Dodds; Jason W Brooks; Mary J Kennett; Edward C Holmes; Andrew F Read
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

Review 4.  An overview of the lagomorph immune system and its genetic diversity.

Authors:  Ana Pinheiro; Fabiana Neves; Ana Lemos de Matos; Joana Abrantes; Wessel van der Loo; Rose Mage; Pedro José Esteves
Journal:  Immunogenetics       Date:  2015-09-23       Impact factor: 2.846

Review 5.  The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.

Authors:  Jia Liu; Sonia Wennier; Grant McFadden
Journal:  Microbes Infect       Date:  2010-09-09       Impact factor: 2.700

6.  Genetic variation at chemokine receptor CCR5 in leporids: alteration at the 2nd extracellular domain by gene conversion with CCR2 in Oryctolagus, but not in Sylvilagus and Lepus species.

Authors:  C R Carmo; P J Esteves; N Ferrand; W van der Loo
Journal:  Immunogenetics       Date:  2006-04-05       Impact factor: 2.846

7.  Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.

Authors:  Jia Liu; Sonia Wennier; Mary Reinhard; Edward Roy; Amy MacNeill; Grant McFadden
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

8.  Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.

Authors:  Mónica Morales; Miguel A Ramírez; María J Cano; Mario Párraga; Joaquín Castilla; Luis I Pérez-Ordoyo; Juan M Torres; Juan Bárcena
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

9.  Myxoma Virus M083 Is a Virulence Factor Which Mediates Systemic Dissemination.

Authors:  A M Wolfe; K M Dunlap; A C Smith; M Y Bartee; E Bartee
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

10.  Detection of myxoma viruses encoding a defective M135R gene from clinical cases of myxomatosis; possible implications for the role of the M135R protein as a virulence factor.

Authors:  Graham J Belsham; Charlotta Polacek; Solvej Ø Breum; Lars E Larsen; Anette Bøtner
Journal:  Virol J       Date:  2010-01-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.